Nanocarrier-Based Immunotherapy

Emerging Frontiers in Cancer

Häftad, Engelska, 2027

AvBhupendra G. Prajapati,Devesh U. Kapoor

2 289 kr

Kommande

Nanocarrier-Based Immunotherapy: Emerging Frontiers in Cancer explores innovative nanotechnology approaches to enhance cancer immunotherapy. This comprehensive volume addresses the design, mechanisms, and clinical potential of nanocarriers such as polymeric nanoparticles, liposomes, dendrimers, exosomes, and inorganic nanomaterials in modulating immune responses against tumors. The book provides in-depth coverage of foundational principles, recent advancements, and translational strategies. It discusses how nanocarriers improve targeted delivery, overcome tumor immune evasion, and enable combination therapies. Chapters highlight cutting-edge topics like AI integration, safety profiles, and regulatory considerations, offering a multidisciplinary perspective. Designed for an academic audience, this resource facilitates understanding of nanomedicine’s role in cancer treatment. It equips researchers, clinicians, and students with scientific insights, novel strategies, and practical solutions to accelerate the development of next-generation immunotherapies.

Bridges fundamental research and translational medicine-covering safety, regulatory issues, and scalability for clinical deployment.
Highlights recent technological innovations and clinical applications-including AI integration, exosome engineering, and inorganic nanomaterials
Provides a comprehensive overview of nanocarrier systems

Produktinformation

Utgivningsdatum2027-01-01
Mått191 x 235 x undefined mm
FormatHäftad
SpråkEngelska
Antal sidor290
FörlagElsevier Science
ISBN9780443444685

Tillhör följande kategorier

Biologi inom Naturvetenskap och teknik

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.

1. Foundations of Nanocarrier-Based Immunotherapy2. Polymeric Nanoparticles as Vectors3. Liposome-Engineered Immunostimulatory Platforms4. Dendrimer-Based Drug Delivery Systems5. Engineered Exosomes in Cancer Immunotherapy6. Inorganic Nanoparticles in Immune Modulation7. Carbon Nanotubes: Design and Safety8. Graphene Oxide Nanocomposites9. Injectable Hydrogels for Cancer Immunotherapy10. Nanoemulsions and Nanosuspensions11. Nanorods and Nanospheres in Precision Immunotherapy12. AI and Nanocarrier Synergy13. Regulation, Safety, and Clinical Trials